Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
GPCR · NASDAQ · Pharmaceutical Preparations
Structure Therapeutics (GPCR) · oqro.io/stocks/GPCR · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$20.00+0.16 (+0.81%)
Close of Nov 13, 2026, vs Nov 12 · end-of-day, not a live quote
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Fund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Deep Track Capital, LP disclosed an increased position in GPCR for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Orbimed Advisors LLC disclosed an increased position in GPCR for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
RTW Investments, LP disclosed a new position in GPCR for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Paradigm Biocapital Advisors LP no longer reported GPCR for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Deerfield Management Company, L.P. disclosed an increased position in GPCR for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Driehaus Capital Management LLC disclosed a reduced position in GPCR for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 13, 2026
Siren, L.L.C. disclosed a reduced position in GPCR for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 13, 2026
Capitolis Liquid Global Markets LLC disclosed a reduced position in GPCR for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Paradigm Biocapital Advisors LP disclosed a new position in GPCR for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Deep Track Capital, LP disclosed an increased position in GPCR for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Longaeva Partners L.P. no longer reported GPCR for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Orbimed Advisors LLC disclosed an increased position in GPCR for Q1 2026Fund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Mar 16, 2026
Avoro Capital Advisors LLC disclosed an increased position in GPCR for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Longaeva Partners L.P. disclosed a new position in GPCR for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Deerfield Management Company, L.P. disclosed an increased position in GPCR for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Driehaus Capital Management LLC disclosed an increased position in GPCR for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Ra Capital Management, L.P. no longer reported GPCR for Q4 2025Fund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Avoro Capital Advisors LLC disclosed a new position in GPCR for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Paradigm Biocapital Advisors LP disclosed a new position in GPCR for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Deep Track Capital, LP disclosed a reduced position in GPCR for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Baker Bros. Advisors LP disclosed a reduced position in GPCR for Q3 2025Fund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Deep Track Capital, LP disclosed an increased position in GPCR for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Orbimed Advisors LLC disclosed an increased position in GPCR for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Baker Bros. Advisors LP disclosed an increased position in GPCR for Q2 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Deep Track Capital, LP disclosed an increased position in GPCR for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Driehaus Capital Management LLC disclosed a reduced position in GPCR for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 14, 2025
Bellevue Group AG disclosed a reduced position in GPCR for Q1 2025SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Deep Track Capital, LP disclosed an increased position in GPCR for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Orbimed Advisors LLC disclosed an increased position in GPCR for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Deerfield Management Company, L.P. disclosed a reduced position in GPCR for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Ra Capital Management, L.P. disclosed a reduced position in GPCR for Q4 2024Fund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Duquesne Family Office no longer reported GPCR for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Deep Track Capital, LP disclosed an increased position in GPCR for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Orbimed Advisors LLC disclosed an increased position in GPCR for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Driehaus Capital Management LLC disclosed a reduced position in GPCR for Q3 2024Politician trade (Senate) · Transaction Oct 4, 2023 · Disclosed Nov 2, 2023
Disclosed sale of GPCR — reported range $1,001 - $15,000SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Driehaus Capital Management LLC disclosed a reduced position in GPCR for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 14, 2026
Siren, L.L.C. disclosed an increased position in GPCR for Q1 2026SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Paradigm Biocapital Advisors LP no longer reported GPCR for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Orbimed Advisors LLC disclosed an increased position in GPCR for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Baker Bros. Advisors LP disclosed a reduced position in GPCR for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Deep Track Capital, LP disclosed a reduced position in GPCR for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Siren, L.L.C. disclosed an increased position in GPCR for Q4 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Orbimed Advisors LLC disclosed a reduced position in GPCR for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 13, 2025
Siren, L.L.C. disclosed a new position in GPCR for Q3 2025SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Driehaus Capital Management LLC disclosed a reduced position in GPCR for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Bellevue Group AG disclosed a reduced position in GPCR for Q4 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Bellevue Group AG disclosed an increased position in GPCR for Q3 2024Source